Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism.

Patients affected by primary aldosteronism (PA) display an increased risk of cardiovascular events compared with essential hypertension (EH). Endothelial dysfunction favors initiation and progression of atherosclerosis and circulating extracellular vesicles (EVs), reflecting endothelial cell activity, could represent one of the mediators of endothelial dysfunction in these patients. The aim of this study was to characterize circulating EVs from patients diagnosed with PA and to explore their functional significance. Serum EVs were isolated from 12 patients with PA and 12 with EH, matched by sex, age, and blood pressure, and compared with 8 normotensive controls. At nanoparticle tracking analysis, EVs concentration was 2.2× higher in patients with PA ( P=0.033) compared with EH and a significant correlation between EV number and serum aldosterone and potassium levels was identified. Fluorescence-activated cell sorting analysis demonstrated that patients with PA presented a higher absolute number of endothelial-derived EVs compared with both patients with EH and normotensive controls. Through EV mRNA profiling, 15 up-regulated and 4 down-regulated genes in patients with PA compared with EH were identified; moreover, EDN1 was expressed only in patients with PA. Microarray platform was validated by quantative real-time polymerase chain reaction on 4 genes ( CASP1, EDN1, F2R, and HMOX1) involved in apoptosis, inflammation, and endothelial dysfunction. After unilateral adrenalectomy, EVs number and expression of CASP1 and EDN1 significantly decreased in patients with PA ( P<0.05). Additionally, the incubation with PA-derived EVs reduced angiogenesis and induced apoptosis in vitro. Circulating EVs might not only represent a marker of endothelial dysfunction but also contribute themselves to vascular dysfunction in patients with PA.

[1]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[2]  Cory B. Giles,et al.  Endothelial dysfunction and angiogenesis impairment in the ageing vasculature , 2018, Nature Reviews Cardiology.

[3]  Thomas Kahan,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[4]  W. Young,et al.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.

[5]  F. Veglio,et al.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. , 2017, Journal of the American College of Cardiology.

[6]  N. Câmara,et al.  NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage , 2016, Circulation.

[7]  M. Brizzi,et al.  Charge-based precipitation of extracellular vesicles , 2016, International journal of molecular medicine.

[8]  David S. Wishart,et al.  Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..

[9]  Bin Wang,et al.  Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury , 2016, Oncotarget.

[10]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[11]  N. Kashihara,et al.  Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  A. Nakashima,et al.  Effect of Aldosterone-Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism , 2015, Hypertension.

[13]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[14]  C. Bode,et al.  Role of microparticles in endothelial dysfunction and arterial hypertension. , 2014, World journal of cardiology.

[15]  D. Jahn,et al.  Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes. , 2014, Toxicology and applied pharmacology.

[16]  B. Cain,et al.  Aldosterone alters the chromatin structure of the murine endothelin-1 gene. , 2013, Life sciences.

[17]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[18]  G. Müller,et al.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases , 2012, Diabetes, metabolic syndrome and obesity : targets and therapy.

[19]  Paul J. Harrison,et al.  Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[20]  R. Touyz,et al.  Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[21]  C. Piantadosi,et al.  Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression* , 2011, The Journal of Biological Chemistry.

[22]  L. Ghiadoni,et al.  Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism , 2008, Journal of hypertension.

[23]  U. de Faire,et al.  Retrospective Analysis of Coagulation Factor II Receptor (F2R) Sequence Variation and Coronary Heart Disease in Hypertensive Patients , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Y. Castier,et al.  Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. , 2007, Journal of the American College of Cardiology.

[25]  J Ratajczak,et al.  Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.

[26]  Chantal M Boulanger,et al.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[27]  J. Al Suwaidi,et al.  Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome , 2005, Vascular health and risk management.

[28]  A. Zeiher,et al.  Endothelial Function: Cardiac Events , 2005, Circulation.

[29]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[30]  D. Calhoun,et al.  Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism , 2004, Circulation.

[31]  E. Schiffrin,et al.  Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats , 2004, Hypertension.

[32]  W. Jy,et al.  Elevated plasma endothelial microparticles in preeclampsia. , 2003, American journal of obstetrics and gynecology.

[33]  E. Schiffrin,et al.  Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling , 2003, Hypertension.

[34]  M. Peakman,et al.  Persistent Infection of Human Microvascular Endothelial Cells by Coxsackie B Viruses Induces Increased Expression of Adhesion Molecules 1 , 2003, The Journal of Immunology.

[35]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.

[36]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[37]  A. Struthers,et al.  Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. , 2002, Clinical science.

[38]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[39]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[40]  Ricardo Rocha,et al.  Aldosterone induces a vascular inflammatory phenotype in the rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.

[41]  C. Tortorella,et al.  Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[42]  A. Struthers,et al.  Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. , 2000, Circulation.

[43]  S. Izumo,et al.  Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.

[44]  U. Ikeda,et al.  Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta. , 1995, European journal of pharmacology.

[45]  W. Waldhäusl,et al.  Effect of endothelin-1 in man: impact on basal and adrenocorticotropin-stimulated concentrations of aldosterone. , 1995, The Journal of clinical endocrinology and metabolism.

[46]  F. Veglio,et al.  Plasma immunoreactive endothelin-1 in primary hyperaldosteronism. , 1994, American journal of hypertension.

[47]  A. Lerman,et al.  Intact and altered endothelium in regulation of vasomotion. , 1992, Circulation.

[48]  W. Campbell,et al.  Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells. , 1990, Endocrinology.

[49]  Fiorenzo Gaita,et al.  Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.

[50]  Michael H. Olsen,et al.  ESH / ESC Guidelines for the management of arterial hypertension , 2013 .

[51]  D. Armanini,et al.  Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity. , 2010, Journal of endocrinological investigation.